The SFMR has published over 250 articles on the accuracy, effectiveness, and cost-effectiveness of mammography according to characteristics of women, radiologist's experience and practice, and tumor biology.

 

2024

Miglioretti DL, Abraham L, Sprague BL, Lee CI, Bissell MCS, Ho TQ, Bowles EJA, Henderson LM, Hubbard RA, Tosteson ANA, Kerlikowske K. Impact of false-positive results on return to screening mammography in the Breast Cancer Surveillance Consortium Cohort. Ann Intern Med 2024;177:000-000. doi:10.7326/M24-0123

Kerlikowske K, Esserman L, Tice JA. Screening mammography for 40-year-old women: Whose decision? JAMA Intern Med Published online September 3, 2024. doi:10.1001/jamainternmed.2024.4277

Stout NK, Miglioretti DL, Yu-Ru Su, Lee CI, Abrams L, Alagoz O, de Koning HJ, Hampton JM, Henderson L, Lowry KP, Mandelblatt JS, Onega T, Schechter CB, Sprague BL, Stein S, Trentham-Dietz A, van Ravesteyn NT, Wernli KJ, Kerlikowske K, Tosteson ANA. Comparative effectiveness of breast cancer screening using digital mammography, digital breast tomosynthesis and supplemental MRI by breast density. JAMA Intern Med 2024 Aug 26. doi: 10.1001/jamainternmed.2024.4224.

Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher GH, O’Meara ES, Miglioretti DL, Lee JM, Stout NK, Herschorn SD, Perry H, Weaver DL, MD, Kerlikowske K. Supplemental ultrasound screening performance in women with dense breasts and varying breast cancer risk. Radiology 2024 Aug;312(2):e232380. doi: 10.1148/radiol.232380

Lee JM, Ichikawa L, Kerlikowske K, Buist DSM, Lee CI, Sprague BL, Henderson LM, Onega T, Wernli K. Lowry KP, Stout NK, Tosteson ANA, Miglioretti DL. Relative timing of mammography and MRI for breast cancer screening: Impact on performance outcomes. J Am Coll Radiol 2024 July 3:S1546-1440(24)00597-0. DOI:https://doi.org/10.1016/j.jacr.2024.06.020.

Horng H, Scott C, Winham S, Jensen M, Pantalone L, Mankowski W, Kerlikowske K, Vachon CM, Kontos D, Shinohara RT. Multivariate testing and effect size measures for batch effect detection in radiomic features. Scientific Rep 2024 Jun 17;14(1):13923.

Smith RE, Sprague BL, Henderson LM, Kerlikowske K, Miglioretti DL, Wernli KJ, Onega T, diFlorio-Alexander RM, Tosteson ANA. Breast density knowledge and willingness to delay treatment for additional breast cancer testing among women with a personal history of breast cancer. Breast Can Res 2024;26(1):73. https://doi.org/10.1186/s13058-024-01820-x

Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard BM, Hampton JM, Caswell-Jin JL, Gangnon RE, Lu Y, Sun L, Huang H, Stein S, Quessep EJG, Yang Y, Lu Y, Song J, Munoz DF, Li Y, Kurian AW, Kerlikowske K, O’Meara ES, Sprague BL, Tosteson ANA, Feuer EJ, Berry EJ, Alagoz O, Plevritis SK, Huang X, de Koning HJ, van Ravesteyn NT, Lee SJ, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS. Collaborative modeling of the benefits and harms of different breast cancer screening strategies with mammography: an updated decision analysis. JAMA 2024 Apr 30. doi: 10.1001/jama.2023.24766.

Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard B, Hampton JM, Caswell-Jin J, Lu Y, Gangnon RE, Sun L, Huang H, Stein S, Quessep EG, Yang Y, Lu Y, Li Y, Song J, Muñoz DF, Kurian AW, Kerlikowske K, O’Meara ES, Sprague BL, Tosteson ANA, Berry D, Alagoz O, Plevritis SK, Huang X, de Koning H, van Ravesteyn N, Lee SJ, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS. Breast cancer screening with mammography: An updated decision analysis for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Apr. Report No.: 23-05303-EF-2.

Miglioretti DL, Onega T, Su Y, Zhu W, Stout NK, Wernli KJ, Bissell MCS, de Bie E, Lowry KP, Sprague B, Ho TQH, Schifferdecker KE, Kerlikowske K, Tosteson ANA, for the Breast Cancer Surveillance Consortium. Comparative effectiveness of breast cancer screening and diagnostic tests among Women with Different Breast Densities—The BCSC-ADVANCE Study. Patient-Centered Outcomes Research Institute (PCORI). Washington, DC: Patient‐Centered Outcomes Research Institute (PCORI). 2024 https://doi.org/10.25302/09.2023.PCS.150430370

Hubbard RA, Su YR, Bowles EJA, Ichikawa L, Kerlikowske K, Lowry KP, Miglioretti DL, Tosteson ANA, Wernli KJ, Lee JM. Predicting five-year cumulative absolute risk of interval second breast cancer in women with a personal history of breast cancer. J Natl Cancer Inst 2024 Mar 11:djae063. doi: 10.1093/jnci/djae063.

George M, Paff SQ, Rojo, JW, Powell M, Benz CC, Pope K, Kerlikowske K, Shepard JA, Willis M, Ereman R, Prebil L. Assessment of salivary Cadmium levels and breast density in the Marin Women’s Study. Cancer Med. 2024;13(2):e6973.  https://doi.org/10.1002/cam4.6973

Kerlikowske K, Zhu W, Su YR, Sprague BL, O’Meara ES, Tosteson ANA, Wernli KJ, Miglioretti DL Response to Omoleye, Esserman, Olufunmilayo. J Natl Cancer Inst 2024;116(4):629-630. 

Kerlikowske K, Chen S, Bissell MCS, Lee CI, Tice JA, Sprague BL, Miglioretti DL. Population attributable risk of advanced stage breast cancer by race and ethnicity. JAMA Oncol 2024; 10(2):167-175 doi:10.1001/jamaoncol.2023.5242

Kerlikowske K, Zhu W, Su YR, Sprague DL, Stout TK, Onega T, O’Meara ES, Henderson LM, Tosteson ANA, Wernli K, Miglioretti DL. Supplemental magnetic resonance imaging plus mammography compared to magnetic resonance imaging or mammography by extent of breast density. J Natl Cancer Inst 2024;116(2):249-257. https://doi.org/10.1093/jnci/djad201

*Gard CC, *Tice JA, Miglioretti DL, Sprague BL, Bissell MCS, Henderson LM, Kerlikowske K. Extending the Breast Cancer Surveillance Consortium model of invasive breast cancer. J Clin Oncol 2024;42(7):779-789. doi: 10.1200/JCO.22.02470  *co-first authors

2023

Kerlikowske K, Chen S, Bissell MCS, Lee CI, Tice JA, Sprague BL, Miglioretti DL. Population attributable risk of advanced stage breast cancer by race and ethnicity. JAMA Oncol, Published online December 7, 2023. doi:10.1001/jamaoncol.2023.5242

*Gard CC, *Tice JA, Miglioretti DL, Sprague BL, Bissell MCS, Henderson LM, Kerlikowske K. Extending the Breast Cancer Surveillance Consortium model of invasive breast cancer. J Clin Oncol 2023 Nov 17:JCO2202470. doi: 10.1200/JCO.22.02470 *co-first authors

Kerlikowske K, Zhu W, Su YR, Sprague DL, Stout TK, Onega T, O’Meara ES, Henderson LM, Tosteson ANA, Wernli K, Miglioretti DL. Supplemental magnetic resonance imaging plus mammography compared to magnetic resonance imaging or mammography by extent of breast density. J Natl Cancer Inst 2023 Oct 27. https://doi.org/10.1093/jnci/djad201

Onega T, Abraham L, Lee CI, Henderson LM, Miglioretti DL, Kerlikowske K, Tosteson ANA, Weaver D, Sprague DL, Bowles EJA, diFlorio RM. Performance of digital mammography and digital breast tomosynthesis in detection of invasive lobular and ductal carcinoma. Breast Can Res Treat 2023 Sep 11. doi: 10.1007/s10549-023-07051-6

Lee JM, Ichikawa L, Wernli KJ, Bowles EJA, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM. Impact of surveillance mammography intervals less than one year on performance measures in women with a personal history of breast cancer. Korean J of Radiol 2023;24(8):729-738.

Nyante SJ, Abraham L, Bowles EJA, Lee CI, Kerlikowske K, Miglioretti DL, Sprague BL, Henderson LM. Racial and ethnic variation in diagnostic mammography performance among women reporting a breast lump. Cancer Epidemiol Biomarkers Prev 2023 Jul 13:EPI-23-0289. doi: 10.1158/1055-9965.EPI-23-0289

Kerlikowske K, Bissell MCS, Sprague BL, Tice JA, Tossas KY, Bowles EJA, Ho TQH, Keegan TH, Miglioretti DL. Impact of BMI on prevalence of dense breasts by race and ethnicity. Cancer Epidemiol Biomarkers Prev 2023 Jun 7:OF1-OF7. doi: 10.1158/1055-9965.EPI-23-0049.

Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher G, O’Meara ES, Miglioretti DL, Chen S, Lee LM, Stout NK, Mandelblatt JS, Alsheik N, Herschorn SD, Perry H, Weaver DL, Kerlikowske K. Risk of mammography screening failures among women undergoing breast ultrasound screening in clinical practice. Cancer 2023 Jun 12. doi: 10.1002/cncr.34768.

Sprague BL, Coley RY, Lowry KP, Kerlikowske K, Henderson LM, Su YR, Lee CI, Onega T, Bowles EAJ, Herschorn SD, diFlorio-Alexander RM, Miglioretti DL. Digital breast tomosynthesis versus digital mammography screening performance on successive screening rounds. Radiology 2023;307(5):e223142. doi: 10.1148/radiol.223142

Vachon CM, Scott CG, Norman A, Khanani S, Jensen M, Moritz R, Hruska C, Brandt KR, Winham S, Kerlikowske K. Impact of AI system and volumetric density on risk prediction of interval, screen-detected, and advanced cancer. J Clin Oncol 2023;41(17):3172-3183.

Lee CI, Abraham L, Miglioretti DL, Onega T, Kerlikowske K, Lee JM, Sprague BL, Tosteson ANA, Rauscher G, Bowles EJA, diFlorio RM, Henderson LM. National performance benchmarks for screening digital breast tomosynthesis: update from the Breast Cancer Surveillance Consortium. Radiology 2023; 307(4):e222499. doi: 10.1148/radiol.222499.

Sprague BL, Chen S, Miglioretti DL, Gard CC, Tice JA, Hubbard RA, Bowles EJA, Kaufman PA, Kerlikowske K. Acumulative six-year risk prediction model for screen-detected ductal carcinoma in situ. JAMA Netw Open 2023;6(2):e230166. doi:10.1001/jamanetworkopen.2023.0166

Lowry KP, Ichikawa I, Hubbard RA, Buist DSM, Bowles EJA, Henderson LM, Kerlikowske K, Specht JM, Sprague BL, Wernli KJ, Lee JM. Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status. Cancer 2023;129(8):1173-1182.

Su Yu-Ru, Buist DSM, Lee JM, Ichikawa L, Miglioretti DL, Bowles EJA, Wernli KJ, Kerlikowske K, Tosteson ANA, Lowry KP, Henderson LM, Sprague BL, Hubbard RA. Performance of statistical and machine learning risk prediction models for breast cancer surveillance benefits and failures. Cancer Epidemiol Biomarkers Prev 2023;32(4):561-571.

Ho TQ, Bissell MCS, Lee CI, Lee JM, Sprague BL, Tosteson ANA, Wernli KJ, Henderson LM, Kerlikowske K, Miglioretti DL. Prioritizing screening mammograms for immediate interpretation and diagnostic evaluation based on risk of recall. J Am Coll Radiol 2023;20(3):299-310. DOI:https://doi.org/10.1016/j.jacr.2022.09.030

2022

Tosteson ANA, Schifferdecker KE, Smith RE, Wernli KJ, Zhao W, Kaplan CP, Buist DSM, Henderson LM, Sprague BL, Onega T, Budesky J, Jackson-Nefertiti G, Johnson D, Miglioretti DL, Kerlikowske K. Women’s breast cancer screening confidence by screening modality and breast density: a Breast Cancer Surveillance Consortium Survey Study. J Womens Health 2022;31(11):1547-1556. doi: 10.1089/jwh.2021.0649 

Durham DD, Abraham LD, Roberts MC, Khan CP, Smith RA, Kerlikowske K, Miglioretti DL. Breast cancer diagnosis among women with a family history of breast cancer by relative’s age at breast cancer diagnosis. Cancer 2022;128(24):4232-4240. doi: 10.1002/cncr.34365. 

Lawson MB, Bissell MCS, Miglioretti DL, Eavey J, Chapman CH, Mandelblatt JS, Onega TL, Henderson LM, Rauscher GH, Kerlikowske K, Sprague BL, Bowles EJA, Gard CC, Lange J, Parsian S, Lee CI.  Multilevel predictors of time to diagnosis after abnormal screening mammography by race and ethnicity. JAMA Oncol 2022;8(8):1115-1126.  

Wernli KJ, Smith RE, Henderson LM, Zhao W, Durham DD, Schifferdecker K, Kaplan C, Buist DSM, Kerlikowske K, Miglioretti DL, Onega T, Rauscher G, Sprague BL, Jackson-Nefertiti G, Budesky J, Johnson D, Tosteson ANA. Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density. Breast Can Res Treat 2022 Aug;194(3):607-616. doi: 10.1007/s10549-022-06648-7. 

Nyante SJ, Abraham L, Aiello Bowles EJ, Lee CI, Kerlikowske K, Miglioretti DL, Sprague BL, Henderson LM. Diagnostic mammography performance across racial and ethnic groups in a national network of community-based breast imaging facilities. Cancer Epidemiol Biomarkers Prev 2022 Jun 17:OF1-OF10. doi: 10.1158/1055-9965.EPI-21-1379. 

Kerlikowske K, Su Yu-Ru, Sprague BL, Tosteson ANA, Buist DSM, Onega T, Henderson LM, Alsheik N, Bissell MCS, O’Meara ES, Lee CI, Miglioretti DL. Association of screening with digital breast tomosynthesis vs. digital mammography with risk of interval invasive and advanced cancer. JAMA 2022;327(22):2220-2230. doi:10.100/jama.2022.7672  

Lowry KP, Bissell M, Miglioretti DL, Kerlikowske K, Alsheik N, Macarol T, Bowles EAJ, Buist DSM, Tosteson ANA, Henderson LM, Herschorn SD, Wernli KJ, Weaver DL, Stout NK, Sprague BL. Impact of the COVID-19 pandemic on breast cancer diagnoses in the Breast Cancer Surveillance Consortium. Radiology 2022;303(2):287-294. https://doi.org/10.1148/radiol.2021211808 

Kerlikowske K, Chen S, Golmakani MK, Sprague BL, Tice JA, Tosteson ANA, Rauscher GH, Henderson LM, Buist DSM, Lee JM, Gard CC, Miglioretti DL. Development of a cumulative advanced breast cancer risk prediction model in a screening mammography population. J Natl Cancer Inst 2022, https://doi.org/10.1093/jnci/djac008

Tice JA, Gard CC, Miglioretti DL, Sprague BL, Tosteson ANA, Joe BN, MD, Hoang Ho TQ, Kerlikowske K. Is mammographic density assessment different for tomosynthesis compared with digital mammography?  Radiology 2022;302(2):286-292. doi: 10.1148/radiol.2021204579 

Lowry KP, Callaway KC, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, Kerlikowske K, Wernli KJ, Kurian AW, Henderson LM, Stout NK. Trends in annual surveillance mammography participation among breast cancer survivors from 2004 to 2016. J Natl Comprehensive Cancer Netw. 2022 Apr;20(4):379-386.e9. doi: 10.6004/jnccn.2021.7081.

Smith RE, Sprague BL, Henderson LM, Kerlikowske K, Miglioretti DL, Buist DSM, Wernli KJ, Onega T, Schifferdecker K, Jackson-Nefertiti G, Johnson D, Budesky J, Tosteson ANA. Breast density knowledge in a screening mammography population exposed to density notification. J Am Coll Radiol 2022 Mar 24:S1546-1440(22)00248-4. doi: 10.1016/j.jacr.2022.02.025. 

Houssami N, Kerlikowske K. AI as a new paradigm for risk-based screening for breast cancer. Nat Med 2022;28(1):29-30. https://doi.org/10.1038/s41591-021-01649-3

Schousboe JT, Sprague BL, Abraham L, O’Meara ES, Onega T, Advani S, Henderson L, Wernli K, Zhang D, Miglioretti DL, Braithwaite D, Kerlikowske K.  Cost-effectiveness of screening mammography beyond age 75, according to comorbidity score and screening frequency. Ann Intern Med 2022;175(1):11-19. doi:10.7326/M20-8076. Published online 23 November 2021.

Advani SM, Abraham L, Buist DSM, Miglioretti DL, Sprague BL, Henderson LM, Onega T, Schousboe J, Demb J, Zhang D, Walter LC, Kerlikowske K, Miglioretti DL, Lee CI, Braithwaite D, O’Meara ES, for the Breast Cancer Surveillance Consortium. Breast biopsy patterns and findings among older women undergoing screening mammography: the role of age and comorbidity. J Geriatr Oncol 2022 Mar;13(2):161-169. 

Ho TQ, Bissell MCS, Kerlikowske K, Hubbard RA, Sprague BL, Lee CI, Tice JA, Tosteson ANA, Miglioretti DL. Cumulative probability of false positive results after 10 years of screening with digital breast tomosynthesis vs. digital mammography. JAMA Netw Open Mar 1;5(3):e222440. doi: 10.1001/jamanetworkopen.2022.2440

Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, van Ravesteyn NT, Weaver D, Yaffe M, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME. Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis. JAMA Oncol Published online February 17, 2022. doi:10.1001/jamaoncol.2021.6204

Onega T, Zhu W, Kerlikowske K, Miglioretti DL, Lee CI, Henderson LM, Tosteson ANA, Wernli KJ, diFlorio R, Weaver D, Buist DSM.  Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield. Breast Can Res Treat 2022 Jan;191(1):177-190. doi: 10.1007/s10549-021-06418-x 

Zhang D, Abraham L, Sprague BL, Onega T, Advani S, Demb J, Miglioretti DL, Henderson LH, Wernli K, Walter LC, Kerlikowske K, Schousboe JT, Braithwaite D, Chrischilles E, O’Meara ES for the Breast Cancer Surveillance Consortium. Mammography adherence in relation to function-related indicators in older women: evidence from the Breast Cancer Surveillance Consortium-Medicare Cohort. Prev Med 2022 Jan;154:106869. doi: 10.1016/j.ypmed.2021.106869.  

Grayek E, Yang Y, Fischhoff B, Schifferdecker KE, Woloshin S, Kerlikowske K, Miglioretti DL, Tosteson ANA. Eliciting women’s preferences for breast cancer screening frequency. Med Decis Making 2022 Jan 22:272989X211073320. doi: 10.1177/0272989X211073320

2021

Acciavatti RJ, Cohen EA, Maghsoudi OH, Gastounioti A, Pantalone L, Hsieh MK, Conant EF, Scott CG, Winham SJ, Kerlikowske K, Vachon CM, Maidment ADA, Kontos D.  Incorporating robustness to imaging physics into radiomic feature selection for breast cancer risk estimation. Cancers 2021 Nov;13(21), 5497; https://doi.org/10.3390/cancers13215497 (registering DOI)

Durham DD, Roberts MC, Khan CP, Abraham LD, Smith RA, Kerlikowske K, Miglioretti DL. Age at initiation of screening mammography by family history of breast cancer in the Breast Cancer Surveillance Consortium. Cancer Causes Control 2021 Oct;32(1):103-107. https://doi.org/10.1007/s10552-020-01354-5

Schifferdecker KE, Vaclavik D, Wernli KJ, Tosteson ANA, Buist DSM, Kerlikowske K, Sprague DL, Henderson LM, Johnson D, Budesky J, Jackson-Nefertiti G, Miglioretti DL. Women’s considerations and experiences for breast cancer screening during the COVID pandemic in the United States: A focus group study. Prev Med 2021 Oct;151:xx-xx. https://doi.org/10.1016/j.ypmed.2021.106542

Sprague BL, O’Meara E, Lee CI, Lee JM, Henderson LM, Buist DSM, Alsheik N, Macarol T, Perry H, Tosteson ANA, Onega T, Kerlikowske K, Miglioretti DL. Prioritizing breast imaging services during the COVID pandemic: a survey of breast imaging facilities within the Breast Cancer Surveillance Consortium. Prev Med 2021 Oct;151:xx-xx.  https://doi.org/10.1016/j.ypmed.2021.106540

Lowry KP, Bissell M, Miglioretti DL, Kerlikowske K, Alsheik N, Macarol T, Bowles EAJ, Buist DSM, Tosteson ANA, Henderson LM, Herschorn SD, Wernli KJ, Weaver DL, Stout NK, Sprague BL. Impact of the COVID-19 pandemic on breast cancer diagnoses in the Breast Cancer Surveillance Consortium. Radiology 2021 Oct 19 https://doi.org/10.1148/radiol.2021211808

Zhu X, Wolfgruber T, Leong L, Scott C, Sadowski P, Vachon CM, Kerlikowske K, Shepherd J. Deep learning predicts interval and screen-detected cancer from screening mammograms: a case-case-control study. Radiology 2021 Sep;000:1–9  https://doi.org/10.1148/radiol.2021203758

Heine J, Fowler E, Scott CG, Jensen MR, Shepherd J, Hruska CB, Winham SJ, Brandt KR, Wu FF, Norman AD, Pankratz VS, Miglioretti DL, Kerlikowske K, Vachon CM. Mammographic variation measures, breast density, and breast cancer risk. Am J Roentgenol 2021 Aug;217(2):326-335. doi: 10.2214/AJR.20.22794

Zhang D, Abraham L, Demb J, Miglioretti DL, Advani S, Sprague BL, Henderson LH, Onega T, Wernli K, Walter LC, Kerlikowske K, Schousboe JT, O’Meara ES, Braithwaite D  for the Breast Cancer Surveillance Consortium. Function-related indicator and outcomes of screening mammography in older women: evidence from the Breast Cancer Surveillance Consortium-Medicare Cohort. Cancer Epidemiol Biomarkers Prev 2021 Aug;30(8):1582-1590. DOI:10.1158/1055-9965.EPI-21-0152

Leong L, Markov S, Drukker K, Niell B, Wolfgruber T, Greenwood H, Joe B, Kerlikowske K, Giger M, Shepherd JA. Dual-energy three compartment breast imaging (3CB) for novel compositional biomarkers to improve detection of malignant lesions. Communications Med, 1, 29 (2021) Aug. https://doi.org/10.1038/s43856-021-00024-0

Advani SM, Zhu W, Demb J, Sprague BL, Onega T, Henderson LM, Buist DSM, Zhang D, Schousboe J, Walter LC, Kerlikowske K, Miglioretti DL, Braithwaite D, for the Breast Cancer Surveillance Consortium. Breast cancer risk by breast density, body mass index and age among older women. JAMA Netw Open 2021 Aug 2;4(8):e2122810. doi: 10.1001/jamanetworkopen.2021.22810

Kerlikowske K, Bissell M, Sprague BL, Buist DSM, Henderson LM, Lee JM, Miglioretti DL Response to Pisano, Gastonis, Sparano, et al. 2021 J Natl Cancer Inst 2021;113(7):940–941.

Kerlikowske K, Bissell M, Sprague BL, Buist DSM, Henderson LM, Lee JM, Miglioretti DL. Advanced breast cancer definitions by staging system examined in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2021 Jul;113(7):909–916.

Alagoz O, Lowry KP, Kurian AW, Mandelblatt J, Ergun MA, Huang H, Lee SJ, Schechter C, Tosteson ANA, Miglioretti DL, Trentham-Dietz A, Nyante SJ, Kerlikowske K, Sprague BL, Stout NK. Impact of disruptions in breast cancer control due to the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling. J Natl Cancer Inst 2021 Jul 14:djab097. doi: 10.1093/jnci/djab097.

Sprague BL, Lowry KP, Miglioretti DL, Alsheik N, Bowles EJA, Tosteson ANA, Rauscher G, Herschorn SD, Lee JM, Trentham-Dietz A, Weaver DL, Stout NK, Kerlikowske K. Changes in screening and diagnostic mammography volume by women’s characteristics during the first five months of the COVID-19 pandemic within the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2021 March 29 https://doi.org/10.1093/jnci/djab045

Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O’Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli, Lee JM, Lee CI. A risk-based approach for scheduling mammography examinations during periods of reduced capacity. JAMA Netw Open 2021;4(3):e211974.

Lee CI, Zhu W, Onega T, Henderson LM, Kerlikowske K, Sprague BL, Rauscher GH, O’Meara ES, Tosteson ANA, Haas JS, diFlorio-Alexander R, Kaplan C, Miglioretti DL. Comparative access to and use of digital breast tomosynthesis screening by women’s race, ethnicity, and socioeconomic status. JAMA Netw Open 2021;4(2):e2037546. doi:10.1001/jamanetworkopen.2020.37546

Lee JM, MD, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K, Migliorett DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM. Digital mammography performance and outcomes in women with a personal history of breast cancer, 2007-2016. Radiology 2021 May 18:204581. doi: 10.1148/radiol.2021204581 

Kerlikowske K, Bibbins-Domingo K. Towards risk-based breast cancer screening: the importance of assessing breast density combined with other risk factors. Ann Intern Med 2021 Feb 8: https://doi.org/10.7326/M21-0398

Rustagi AS, Scott CG, Winham S, Brandt K, Aaron N, Jensen M, Hruska CB, Heine J, Pankratz VS Kerlikowske K, Vachon C. Association of daily alcohol intake, volumetric breast density and breast cancer risk. JNCI Spectrum 2021;5(2), https://doi.org/10.1093/jncics/pkaa124

van Ravesteyn NT, Schechter CB, Hampton JM, Alagoz O³, van den Broek JJ, Kerlikowske K, Mandelblatt JS, Miglioretti DL, Sprague BL, Stout NK, de Koning HJ, Trentham-Dietz A, Tosteson ANA. Trade-offs between harms and benefits of different screening intervals among women at lower than average risk of breast cancer. J Natl Cancer Inst 2021 Jan 31 https://doi.org/10.1093/jnci/djaa218

Kleinstern G, Scott CG, Tamimi RM , Jensen MR, Pankratz VS, Bertrand KA,  Norman AD, Visscher DW, Couch FJ, Brandt K, Shepherd J, Wu FF, Cummings SR, Winham S,  Kerlikowske K, Vachon CM. Association of mammographic density measures and breast cancer ‘intrinsic’ molecular subtypes. Breast Cancer Res Treat 2021 Jan 4. doi: 10.1007/s10549-020-06049-8.

2020

Bissell MCS, Kerlikowske K, Sprague BL, Tice JA, Gard CC, Tossas-Milligan KY, Rauscher GH, Trentham-Dietz A, Henderson LM, Onega T, Keegan TH, Miglioretti DL. Population-attributable risk of body mass index and breast density for breast cancer by race/ethnicity. Cancer Epidemiol Biomarkers Prev July 29 2020 DOI: 10.1158/1055-9965.EPI-20-0358

Lowry KP, Coley RY, Miglioretti DL, Kerlikowske K, Henderson LM, Onega T, Sprague BL, Lee JM, Herschorn S, Tosteson ANA, Rauscher G, Lee CI. Differences in screening performance with digital breast tomosynthesis compared to digital mammography by breast density, age, and screening round. JAMA Netw Open 2020 Jul 1;3(7):e2011792. doi: 10.1001/jamanetworkopen.2020.11792

Kenny J, Karliner L, Kerlikowske K, Kaplan C, Fernandez-Lamothe A, Burke N. Health system communication factors and abnormal mammogram follow-up: A qualitative study across three healthcare systems.  J Gen Intern Med 2020 Jun 29. doi: 10.1007/s11606-020-05972-2.

Kerlikowske K, Bissell M, Sprague BL, Buist DSM, Henderson LM, Lee JM, Miglioretti DL. Advanced breast cancer definitions by staging system examined in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2020;112(2) https://doi.org/10.1093/jnci/djaa176

Durham DD, Roberts MC, Khan CP, Abraham LD, Smith RA, Kerlikowske K, Miglioretti DL. Age at initiation of screening mammography by family history of breast cancer in the Breast Cancer Surveillance Consortium. Cancer Causes Control 2020 https://doi.org/10.1007/s10552-020-01354-5

Demb J, Abraham L, Miglioretti DL, Sprague BL, O’Meara ES, Advani S, Henderson LM, Onega T, Buist DSM, Schousboe JT, Walter LC, Kerlikowske K, Braithwaite D, for the Breast Cancer Surveillance Consortium. Screening mammography outcomes: Risk of breast cancer and mortality by comorbidity score and age. J Natl Cancer Inst 2020;112(6):599-606.

Schifferdecker KE, Tosteson ANA, Kaplan C, Kerlikowske K, Buist DSM, Henderson LM, Johnson D, Jaworski J, Jackson-Nefertiti G, Ehrlich K, Marsh MW, Vu L, Onega T, Wernli KJ. Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed". J Gen Intern Med. 2020 Jun. PMID: 31792869

Henderson LM, O’Meara ES, Haas JS, Lee CI, Kerlikowske K, Sprague BL, Alford-Teaster J, Onega T. The role of social determinants of health in self-reported access to healthcare among women undergoing screening mammography. J Women’s Health2020 May 5. doi: 10.1089/jwh.2019.8267

Sprague BL, Miglioretti DL, Lee CI, Perry H, Tosteson ANA, Kerlikowske K. New mammography screening performance metrics based on the entire screening episode. Cancer 2020; May 6. doi: 10.1002/cncr.32939

Sprague BL, Coley RY, Kerlikowske K, Rauscher GH, Henderson LM, Onega T, Lee CI, Herschorn SD, Tosteson ANA, Miglioretti DL. Assessment of Radiologist Performance in Breast Cancer Screening Using Digital Breast Tomosynthesis vs Digital Mammography. JAMA Netw Open. 2020 Mar 02; 3(3):e201759. PMID: 32227180

Buist DSM, Ichikawa L, Wernli KJ, Lee CI, Henderson LM, Kerlikowske K, Bowles EJA, Miglioretti DL, Specht J, Rauscher G, Sprague B, Onega T, Lee JM. Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization. J Am Coll Radiol. 2020 Jan 28. PMID: 32004483

2019

Brandt KR, Scott CG, Miglioretti DL, Jensen MR, Mahmoudzadeh A, Hruska C, Ma L, Wu FF, Cummings SR, Norman AD, Engmann N, Shepherd JA, Winham S, Kerlikowske K,* Vachon CM. Asymmetrical changes in automated volumetric breast density measures prior to breast cancer diagnosis. *co-senior authors Breast Cancer Res2019;21 (1):118. doi: 10.1186/s13058-019-1198-9

Demb J, Abraham L, Miglioretti DL, Sprague BL, O’Meara ES, Advani S, Henderson LM, Onega T, Buist DSM, Schousboe JT, Walter LC, Kerlikowske K, Braithwaite D, for the Breast Cancer Surveillance Consortium. Screening outcomes among older women undergoing mammography: Comorbidity and age’s effect on cumulative risk of breast cancer and non-breast cancer death. J Natl Cancer Inst2019  djz172, https://doi.org/10.1093/jnci/djz172

Henderson LM, Ichikawa L, Buist DSM, Lee J, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague DL, Wernli KJ. Patterns of breast imaging use among women with a personal history of breast cancer. J Gen Intern MedAug 13. doi: 10.1007/s11606-019-05181-6. [Epub ahead of print]

Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, Buist DSM, Onega T, Henderson LM, O’Meara ES, Miglioretti DL. Identifying women at high-risk of advanced cancers for discussion of supplemental imaging. JAMA Intern MedJuly 1 doi:10.1001/jamainternmed.2019.1758. [Epub ahead of print]

Hinton B, Ma L, Mahmoudzadeh AP, Malkov S, Fan B, Greenwood H, Joe B, Lee V, Kerlikowske K, Shepherd J. Deep learning networks find unique mammographic differences of interval versus screening detected cancers: a case-case analysis. Cancer Imaging2019;19:41. https://doi.org/10.1186/s40644-019-0227-3

Engmann NJ, Scott CG, Jensen MR, Winham S, Ma L, Brandt K, Mahmoudzadeh A, Whaley DH, Hruska C, Wu F, Norman AD, Hiatt RA, Heine J, Shepherd J, Pankratz VS, Miglioretti DL, Kerlikowske K,* Vachon CM.* Longitudinal changes in volumetric breast density in healthy women across the menopausal transition. Cancer Epidemiol Biomarkers Prev2019;28(8):1324-1330; DOI:10.1158/1055-9965.EPI-18-1375

Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM,DeMartini W,Brandzel SD, Bush M,  Johnson D, Henderson LM, Nekhlyudov L, Onega T, Rosenberg D, Sprague BL, Lee JM, Lehman C, Miglioretti DL. Surveillance breast MRI and mammography performance measures in women with a personal history of breast cancer. Radiology2019;292(2):311-318. doi: 10.1148/radiol.2019182475

Kerlikowske K, Miglioretti DL, Vachon CM.Breast density information for primary care providers to facilitate discussions of dense breasts, breast cancer risk and screening choices in 2019.  JAMAMay 31. doi:10.1001/jama.2019.6247.[Epub ahead of print]

Engmann NJ, Scott CG, Jensen MR, Winham S, Miglioretti DL, Ma L, Brandt K, Mahmoudzadeh A, Whaley DH, Hruska C, Wu F, Norman AD, Hiatt RA, Heine J, Shepherd J, Pankratz VS, Vachon CM*, Kerlikowske K.* Combined effect of volumetric breast density and body mass index on breast cancer risk. Breast Cancer Res Treat2019;177(1):165-173.

Shieh Y, Scott CG, Jensen MR, Norman A, Bertrand KA, Pankratz VS, Brandt K, Shepherd J,Tamimi RM, Vachon CM, Kerlikowske K. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype. Breast Cancer Res 2019;21(1):48. doi: 10.1186/s13058-019-1129-9.

Lee JM, Arao RF, Sprague BL,Kerlikowske K, Lehman CD, Smith R, Henderson LM, Rauscher GH, Miglioretti DL. Performance of screening ultrasound as an adjunct to screening mammography. JAMA Intern Med2019 Mar 18. doi: 10.1001/jamainternmed.2018.8372

Miglioretti DL, Abram L, Lee CI, Buist DSM, Herschorn S, Sprague BL, Henderson LM, Tosteson ANA, Kerlikowske K. The learning curve of screening with digital breast tomosynthesis. Radiology2019;291(1):34-42. doi: 10.1148/radiol.2019182305

Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, Kerlikowske K. Validation of the Breast Cancer Surveillance Consortium model of breast cancer risk. Breast Cancer Res Treat2019 2019;175(2):519-523.

Hinton B, Ma L, Mahmoudzadeh AP, Malkov S, Avila J, Fan B, Greenwood H, Joe B, Lee V, Strand F, Kerlikowske K, Shepherd J. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis. Med Phys 2019;46(3):1309-1316. 

Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega TL, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K. Population-based assessment of the effect of MRI background parenchymal enhancement on future primary breast cancer risk. J Clin Oncol 2019; 37(12):954-963. doi: 10.1200/JCO.18.00378. 

Sprague BL, Kerlikowske K, Bowles EJA, Rauscher GH, Lee CI, Tosteson ANA, Miglioretti DL. Trends in clinical breast density assessment from the Breast Cancer Surveillance Consortium. J Natl Cancer Inst2019 Jan 8. doi: 10.1093/jnci/djy210. 

Drukker K, Duewer FW, Giger ML, Malkov S, Flowers C, Joe B, Kerlikowske K, Drukteinis J, Li H, Shepherd, JA. Combined benefit of quantitative three-compartment breast image analysis to mammography radiomics in the classification of breast masses on a clinical dataset Radiology2019;290(3):621-628.

Karliner LS, Kaplan CP, Livaudais-Toman J, Vittinghoff E, Kerlikowske K. Mammography facilities serving vulnerable women have longer follow-up times. HSR2019 Feb;54 Suppl 1:226-233.

2018

Lee CI, Zhu W, Onega TL, Germino J, O’Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL. The effect of digital breast tomosynthesis adoption on facility-level breast cancer screening volume. Am J Rotengol, 2018;211(5):957-963. doi: 10.2214/AJR.17.19350

Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA. Cumulative risk distribution for interval invasive second breast cancers after negative surveillance mammography. J Clin Oncol. 2018 Jul  doi: 10.1200/JCO.2017.76.82. PMID: 29718790

Onega T, Zhu W, Weiss JE, Goodrich M, Tosteson ANA, DeMartini W, Virnig BA, Henderson LM, Buist DSM, Wernli KJ, Kerlikowske K, HubbardR. Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat 2018 Jul; doi: 10.1007/s10549-018-4732-z. PMID: 29516372

Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Collins LC, Cummings SR, Kerlikowske K, Vachon C. Does mammographic density mediate risk factor associations with breast cancer subtypes? Breast Cancer Res Treat 2018 Jul; doi: 10.1007/s10549-018-4735-9. PMID: 29502324

Kerlikowske K, Scott GG, Mahmoudzadeh A, Ma L, Winham S, Jensen MR, Wu FF, Malkov S, Pankratz VS, Cummings SR, Shepherd J, Brandt KR, Miglioretti DL, Vachon CM. Automated and clinical BI-RADS breast density measures predict risk of screen-detected and interval cancers. Ann Intern Med 2018 Jun 5; doi:10.7326/M17-3008. PMID: 29710124

Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O’Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T. Breast biopsy intensity and findings following breast cancer screening in women with and without a personal history of breast cancer. JAMA Intern Med 2018 Apr. doi: 10.1001/jamainternmed.2017.8549. PMID: 29435556

Braithwaite D, Miglioretti DL, Weiwei Z, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K, for the Breast Cancer Surveillance Consortium. Family history and breast cancer risk among older women in the Breast Cancer Surveillance Consortium cohort. JAMA Intern Med 2018 Apr; 178(4):494-501. doi: 10.1001/jamainternmed.2017.8642. PMID: 29435563

Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout N, Tosteson ANA, Kerlikowske K, Onega T. Utilization of breast cancer screening with magnetic resonance imaging in community practice. J Gen Intern Med, 2018 Mar; 33(3):275-283. doi: 10.1007/s11606-017-4224-6. PMID: 29214373

Ray KM, Kerlikowske K, Lobach I, Hofmann M, Greenwood HI, Arasu VN, Hylton NM, Joe BN. Effect of background parenchymal enhancement on breast MRI interpretive performance in community-based practices. Radiology 2018 Mar;170811. doi: 10.1148/radiol.2017170811. PMID: 29072981

2017

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A. Emerging trends in family history of breast cancer and associated risk. Cancer Epidemiol Biomarkersand Prev, 2017 Dec pii: cebp.0531.2017. doi: 10.1158/1055-9965.EPI-17-0531. PMID: 28986348

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD. Performance benchmarks for screening breast MRI for the Breast Cancer Surveillance Consortium. Radiology 2017 Oct. 285(1):44-52. doi: 10.1148/radiol.2017162033. PMID: 28582633

Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller BA, Monsees B, Onega T, Rosenberg RD, Sickles EA, Yankaskas B,Kerlikowske K. Correlation between screening mammography interpretive performance on a test set and performance in clinical practice. Acad Radiol  2017 Oct. 24(10):1256-1264. doi: 10.1016/j.acra. PMID: 28551400 

Kerlikowske K, Ma L, Scott GG, Mahmoudzadeh A, Jensen MR, Sprague BL, Henderson LM, Pankratz VS, Cummings S, Miglioretti DL, Vachon CM, Shepherd J. Combining quantitative and qualitative breast density measures to assess breast cancer risk. Breast Cancer Res 2017 Aug; 19(1):97 doi.org/10.1186/s13058-017-0887-5. PMID: 28830497

Yaghjyan L, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Pankratz VS, Brandt K, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings S, Kerlikowske K, Vachon CM. Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes. Breast Cancer Res Treat 2018 2017 Sep; doi: 10.1007/s10549-017-4341-2. PMID: 28624977

Nguyen KH, Pasick RJ, Stewart SL, Kerlikowske K, Karliner LS. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups. Cancer 2017 Sep 15. DOI: 10.1002/cncr.30756. PMID: 28603859

Tice JA, Kerlikowske K. Supplemental breast cancer screening: A density conundrum. J Gen Intern Med 2017 Jun. doi: 10.1007/s11606-017-3989-y (invited editorial). PMID: 28243876

Engmann NJ, Scott CG, Jensen MR, Ma L, Brandt K, Mahmoudzadeh A, Malkov S, Whaley DH, Hruska C, Wu F, Winham S, Miglioretti DL, Norman AD, Heine J, Shepherd J, Pankratz VS, Vachon CM, Kerlikowske K. Longitudinal changes in volumetric breast density with selective estrogen receptor modulators. Cancer Epidemiol Biomarkersand Prev 2017 June. pii: cebp.0882.2016. doi: 10.1158/1055-9965.EPI-16-0882. PMID: 28148596

Ahern TP, Sprague BL, Bissell M, Miglioretti DL, Buist DSM, Braithwaite D, Kerlikowske K.
Family history of breast cancer, breast density, and breast cancer risk in a U.S. breast cancer screening population. Cancer Epidemiol Biomarkers Prev 2017 Jun. pii: cebp.0801.2016. doi: 10.1158/1055-9965.EPI-16-0801. PMID: 28096200

Lehman CD, Arao R, Sprague BL, Lee JM, Buist DSM, Kerlikowske K, Henderson LM, Onega T, Tosteson ANA, Rauscher GH, Miglioretti DL. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology 2017 Apr;283(1):49-58. PMID: 27918707

Sprague BL, Arao R, Miglioretti DL, Henderson LM, Buist DSM, Onega T, Rauscher GH, Lee JM, Tosteson ANA, Kerlikowske K,Lehman CD. National performance benchmarks for modern diagnostic digital mammography: update from the Breast Cancer Surveillance Consortium. Radiology, 2017 Feb. 283(1):59-69. doi: 10.1148/radiol.2017161519. PMID: 28244803

Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, Buist DSM, DeMartini W, Wernli KJ. Women's experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Preference and Adherence 2017 Feb;11:199-204. PMID: 28203064

Ziv E, Tice JA, Sprague B, Vachon CM, Cummings SR, Kerlikowske K. Using breast cancer risk associated polymorphisms to identify women for breast cancer chemoprevention. Plus One 2017 Jan dx.doi.org/10.1371/journal.pone.0168601. PMID: 28107349

Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DMS, Henderson L, Hubbard RA, Goodrich M, Tosteson ANA, Virnig BA, O'Donoghue C. Locoregional treatment of breast cancer in women with and without preoperative MRI. Am J Surg 2017 Jan;  12. pii: S0002-9610(16)30286-0. doi: 10.1016/j.amjsurg.2016.03.014. PMID: 27421187

Malkov S, Shepherd JA, Scott CG, Tamimi RM, Ma L, Bertrand KA, Couch F, Jensen MR, Mahmoudzadeh AP, Fan B, Norman A, Brandt KR, Pankratz VS, Vachon CM, Kerlikowske K. Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.

Breast Cancer Res 2017 Jan.  DOI: 10.1186/s13058-016-0778-1. PMID: 28052757

Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL. Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy. 2017 Jan 1.JAMA Oncol 2017; 3(1):36-41. PMID: 27607465

2016

Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL. Risk factors that increase risk of estrogen receptor positive and negative breast cancer. J Natl Cancer Inst, 2016 Dec 31;109(5). doi: 10.1093/jnci/djw276. PMID: 28040694

Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B. Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol. 2016 November;13(11S):e72-e79. doi: 10.1016/j.jacr.2016.09.035. PMID: 27814827

Goodrich MD, Weiss JE, Onega TL, Balch SL, Buist DSM, Kerlikowske K, Henderson LM, Hubbard RA. The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women. Breast J 2016 23 2016 Nov | DOI: 10.1111/tbj.12651.PMID:  27550072

Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broekk JJ, Alagoz O, Sprague BL, vanRavesteyn MT, Near AM, Gangnon RE, Hampton JM, Chang Y, deKoning HJ, Mandelblatt JS, Tosteson NA. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Ann Intern Med 2016 Nov 15. doi: 10.7326/M16-0476.] PMID: 27548583

Shieh, Y, HuD, Ma L, Huntsman S, Gard CC, Leung JWT, Tice Ja, Vachon CM, Kerlikowske K, Breast Cancer Risk Prediction using a clinical risk model and polygenic riskscore. Breast Cancer Res Treat 2016 Oct; 159(3): 51325 PMID: 27565998

Engmann NJ, Golmakani MK, Miglioretti D, Sprague BL, Kerlikowske K. Population attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol, JAMA Oncol. 2016 Sep 1;3(9):1228-1236. doi: 10.1001/jamaoncol.2016.6326. PMID: 28152151

Hubbard R. O’Meara ES, Henderson LM, Hill D, Braithwaite D, Haas JS, Lee CI, Sprague BL, Alford-Teaster J, Tosteson A, Wernli KJ, Onega T. Multilevel factors associated with long-term adherence to screening mammography in older women. Prev Med. 2016 Aug;89:169-177.

Doi: 10.1016/j.ypmed.2016.05.034. PMID: 27261409

Sherman ME, Ichikawa L, Pfeiffer RM, Miglioretti DL, Kerlikowske K, Tice JA, Vacek PM, Gierach GL. Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients. Plos One 2016 Aug 25;11(8):e0160966. doi: 10.1371/journal.pone.0160966. PMID: 27560501

Onega T, Weiss J, Buist DSM, Tosteson ANA, Henderson LM, Kerlikowske K, Goodrich M, O’Donoghue C, Wernli KJ, DeMartini W, Virnig B, Bennette CS, HubbardR. Breast MRI in the diagnostic and preoperative workup among Medicare beneficiaries with breast cancer. Med Care 2016 Jul; 54(7):719-24. PMID:  27111752

Onega T, Lee CI, Benkeser D, Alford-Teaster J, Haas JS, Tosteson AN, Hill D, Shi X, Henderson LM, Hubbard RA. Travel Burden to Breast MRI and Utilization: Are Risk and Sociodemographics Related? J Am Coll Radiol. 2016 Jun;13(6):611-9. doi: 10.1016/j.jacr.2016.01.022. PMID: 27026577

Lee CI, Bogart A, Germino JC, Goldman LE, Hubbard RA, Haas JS, Hill DA, Tosteson AN, Alford-Teaster JA, DeMartini WB, Lehman CD,Onega TL. Availability of Advanced Breast Imaging at Screening Facilities Serving Vulnerable Populations. J Med Screen. 2016 March; 23:24-30. PMCID: PMC4679713.

Nelson HD, O'Meara ES, Kerlikowske K, Balch S, Miglioretti D. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-0971. [Epub ahead of print] PubMed PMID: 26756902.

Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, Hoeffken A, Chang Y, Heijnsdijk EA, Chisholm G, Huang X, Huang H, Ergun MA, Gangnon R, Sprague BL, Plevritis S, Feuer E, de Koning HJ, Cronin KA. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-1536. [Epub ahead of print] PubMed PMID: 26756606.

Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann Intern Med. 2016 Jan 12. doi: 10.7326/M15-1241. [Epub ahead of print] PubMed PMID: 26756460

Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, Wernli KJ, Sprague BL, Herschorn SD, Lehman CD. Concordance of BI-RADS Assessments and ManagementRecommendations for Breast MRI in Community Practice. AJR Am J Roentgenol. 2016 Jan;206(1):211-6. doi: 10.2214/AJR.15.14356. PubMed PMID: 26700354

Henderson LM, Weiss J, Hubbard RA, O'Donoghue C, DeMartini WB, Buist DS, Kerlikowske K, Goodrich M, Virnig B, Tosteson AN, Lehman CD, Onega T. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer. Breast J. 2016 Jan;22(1):24-34.doi: 10.1111/tbj.12522. Epub 2015 Oct 28. PubMed PMID: 26511204

2015

Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2015 Dec 28. doi:10.1002/cncr.29805. [Epub ahead of print] PubMed PMID: 26709819.

Kerlikowske K. Progress Toward Consensus on Breast Cancer Screening Guidelines and Reducing Screening Harms. JAMA Intern Med. 2015 Dec 1;175(12):1970-1. doi: 10.1001/jamainternmed.2015.6466. PubMed PMID: 26502319.

Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA; Breast Cancer Surveillance Consortium. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol. 2015 Nov 1;1(8):1069-77. doi: 10.1001/jamaoncol.2015.3084. PubMed PMID: 26501844

Onega T, Goldman LE, Walker RL, Miglioretti DL, Buist DS, Taplin S, Geller BM, Hill DA, Smith-Bindman R. Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes. J Med Screen. 2015 Aug 11. pii: 0969141315595254.[Epub ahead of print] PubMed PMID: 26265482.

Brandt KR, Scott CG, Ma L, Mahmoudzadeh AP, Jensen MR, Whaley DH, Wu FF, Malkov S, Hruska CB, Norman AD, Heine J, Shepherd J, Pankratz VS, Kerlikowske K, Vachon CM. Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening. Radiology. 2015 Dec 22:151261. [Epub ahead of print] PubMed PMID: 26694052.

Henderson LM, Hubbard RA, Sprague BL, Zhu W, Kerlikowske K. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram. Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1882-9. doi: 10.1158/1055-9965.EPI-15-0623. PubMed PMID: 26631292

Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP. Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast. 2015 Oct 14. pii: S0960-9776(15)00210-6. doi: 10.1016/j.breast.2015.09.009. [Epub ahead of print], PMID: 26476466

 

2014

Sprague BL, Stout NK, Lee SJ, Schechter CB, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson ANA. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for Women with dense breasts. Epub ahead of print 2014 Dec 9. PMID: 25486550

Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol. 2014 Nov;21(11):13706. doi: 10.1016/j.acra.2014.06.003. PMID: 25126973

Lee CI1, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD. Comparative Effectiveness of Combined Digital Mammography and Tomosynthesis Screening for Women with Dense Breasts. Radiology. 2014 Oct 13:141237. PMID: 25350548

Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C12, Ascunce N, Salas D, Bulliard JL, Segnan N, Kerlikowske K, Taplin S; ICSN DCIS Working group. International variation in management of screen-detected ductal carcinoma in situ of the breast. Eur J Cancer. 2014 Oct;50(15):2695-704. doi: 10.1016/j.ejca.2014.07.019. PMID: 25149183

Kerlikowske K, O'Kane ME, Esserman LJ. Fifty years of age-based screening: time for a new risk-based screening approach. Evid Based Med. 2014 Oct;19(5):183. doi: 10.1136/eb-2014-101798. PMID: 24785471

DeFilippis RA, Fordyce C, Patten K, Chang H, Zhao J, Fontenay GV, Kerlikowske K, Parvin B, Tlsty TD. Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic density. Cancer Res. 2014 Sep 15;74(18):5032-44. doi: 10.1158/0008-5472.CAN-13-3390. Epub 2014 Aug 29. PMID: 25172842

Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, Kerlikowske K, Miglioretti DL. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014 Sep 12;106(10). pii: dju255. doi: 10.1093/jnci/dju255. Print 2014 Oct. PMID: 25217577.

Onega T, Hubbard R, Hill D, Lee C, Haas JS, Carlos HA, Alford-Teaster J, Bogart A, DeMartini WB, Kerlikowske K, Virnig BA, Buist DS, Henderson L, Tosteson AN. Geographic access to breast imaging for US women. J Am Coll Radiol. 2014 Sep;11(9):874-82. doi: 10.1016/j.jacr.2014.03.022. PMID: 24889479

Ayvaci MU, Alagoz O, Chhatwal J, Munoz del Rio A, Sickles EA, Nassif H, Kerlikowske K, Burnside ES. Predicting invasive breast cancer versus DCIS in different age groups. BMC Cancer. 2014 Aug 11;14:584. doi: 10.1186/1471-2407-14-584. PMID: 25112586

Kerlikowske K, Hubbard R, Tosteson AN. Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography. J Natl Cancer Inst. 2014 Jul 16;106(8). pii: dju191. doi: 10.1093/jnci/dju191. Print 2014 Aug. PMID: 25031310

Prebil LA, Ereman RR, Powell MJ, Jamshidian F, Kerlikowske K, Shepherd JA, Hurlbert MS, Benz CC. First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control. 2014 Jul;25(7):859-68. doi: 10.1007/s10552-014-0386-2. PMID: 24801045

Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS. A randomized, controlled trial to increase discussion of breast cancer in primary care. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1245-53. doi: 10.1158/1055-9965.EPI-13-1380. PMID: 24762560

Izano M, Satariano WA, Tammemagi MC, Ragland D, Moore DH, Allen E, Naeim A, Sehl ME, Hiatt RA, Kerlikowske K, Sofrygin O, Braithwaite D. Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity? J Geriatr Oncol. 2014 Jul;5(3):266-75. doi: 10.1016/j.jgo.2014.02.003. PMID: 24613574

Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL. Changes in breast cancer risk distribution among Vermont women using screening mammography. J Natl Cancer Inst. 2014 Jun 23;106(8). pii: dju157. doi: 10.1093/jnci/dju157. Print 2014 Aug. PMID: 24957223

Geller BM, Bogart A, Carney PA, Sickles EA, Smith R, Monsees B, Bassett LW, Buist DM, Kerlikowske K, Onega T, Yankaskas BC, Haneuse S, Hill D, Wallis MG, Miglioretti D. Educational interventions to improve screening mammography interpretation: a randomized controlled trial. AJR Am J Roentgenol. 2014 Jun;202(6):W586-96. doi: 10.2214/AJR.13.11147. PMID: 24848854

Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, hisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun. PMID: 24872543

Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP. Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt). 2014 May;23(5):420-7. doi: 10.1089/jwh.2013.4516. PMID: 24372085

Malkov S, Kerlikowske K, Shepherd J. Automated Volumetric Breast Density derived by Shape and Appearance Modeling. Proc Soc Photo Opt Instrum Eng. 2014 Mar 22;9034:90342T. PMID: 25083119

Drukker K, Duewer F, Giger ML, Malkov S, Flowers CI, Joe B, Kerlikowske K, Drukteinis JS, Li H, Shepherd JA. Mammographic quantitative image analysis and biologic image composition for breast lesion characterization and classification. Med Phys. 2014 Mar;41(3):031915. doi: 10.1118/1.4866221. PMID: 24593733

Drukker CA, Schmidt MK, Rutgers EJ, Cardoso F, Kerlikowske K, Esserman LJ, van Leeuwen FE, Pijnappel RM, Slaets L, Bogaerts J, Van't Veer LJ. Mammographic screening detects low-risk tumor biology breast cancers. Breast Cancer Res Treat. 2014 Feb;144(1):103-11. doi: 10.1007/s10549-013-2830-5. PMID: 24469641

Wernli KJ, O'Meara ES, Kerlikowske K, Miglioretti DL , Muller CY, Onega T, Sprague B, Henderson LM, Buist DS. Investigation of Mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst 2014;Jan 1;106(1). PMID: 24309005

Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD,Onega T, Kerlikowske K, Henderson LM, Geller BM,Hofmann M, Yankaskas BC. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med 2014; Jan1; 174(1):125-32.  PMID: 24247555

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; the ICSN DCIS Working group. Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening Network. Eur J Cancer 2014;Jan;50(1):185-92. PMID: 24041876

Menes T, Rosenberg R, Balch S, Jaffer S, Kerlikowske K, Miglioretti DL. Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium. Am J Surg 2014;  Jan;207(1);24-31.  PMID: 24112677

2013 

Buist DS, Anderson ML, Smith RA, Carney PA, Miglioretti DL, Monsees BS, Sickles EA, Taplin SH, Geller BM, Yankaskas BC, Onega TL. Effect of Radiologists' Diagnostic Work-up Volume on Interpretive Performance. Radiology. 2014 Nov;273(2):351-64. doi: 10.1148/radiol.14132806. PMID: 24960110

Bertrand KA, TamimiRM, Scott CG, Jensen MR, Pankratz VS, Visscher D, NormanA, Couch F, Shepherd J, ChenYY, MaL, Fan B, Beck AH,Willett WC,Cummings SR, Kerlikowske K*, Vachon CM*. Mammographic density and risk of breast cancer by age and tumor characteristics. BreastCancer Res 2013 Nov 4; 15(6). PMID: 24188089

Wang J, Aziz A, Klifa C, Newitt D, Yitta S, Hylton N, Kerlikowske K, Shepherd JA. Agreement of mammographic measures of volumetric breast density to MRI. Plus One 2013 Dec 4;8(12). PMID: 24324712

O’Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus K, Geller B, Wernli K, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer 2013 Vol. 119, Issue 22 (3959–3967),15 November 2013. PMID: 234037812

Carney PA, Bogart A, Sickles EA, Smith R, Buist DSM, Kerlikowske K, Onega T, Miglioretti D, Rosenberg R, Yankaskas B, Geller BM. Feasibility and acceptability of conducting a randomized clinical trial designed to improve interpretation of screening mammography. Acad Radiol 2013 Nov;20(11):1389-98.  PMID: 24119351.

Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DSM, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL. Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst 2013 Sep 18;105(18):1373-84. PMID: 24046390.

Fenton JJ, Onega T, Zhu W, Balch S, Smith-Bindman R, Henerson L, Sprague BL, Kerlikowske K, Hubbard RA. Validation of a medicare claims-based algorithm for identifying breast cancers detected at screening mammography. Medical Care 2013 Aug 6. PMID: 23929404

Tice JA, O'Meara E, Weaver D, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density and the risk for breast cancer. JNCI. Journal of the National Cancer Institute; 2013 July 17;105(14):1043-49. PMID: 23744877.

Braithwaite D, Mandelblatt J, Kerlikowske K. To screen or not to screen older women for breast cancer: a conundrum. Future Oncology 2013 June;9(6):763-766. PMID: 23718292.

Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL. Impact of Mammography Screening Interval on Breast Cancer Diagnosis by Menopausal Status and BMI. J Gen Intern Med. 2013 Nov;28(11);1454-62. PMID: 23760741.

Onega T, Anderson ML, Miglioretti DL, Buist DS, Geller B, Bogart A, Smith RA, Sickles EA, Monsees B, Bassett L, Carney PA, Kerlikowske K, Yankaskas BC.Establishing a gold standard for test sets: variation in interpretive agreement of expert mammographers. Academic Radiology 2103 June;20(6):731-739. PMID: 23664400.

Houssami N, Abraham LA, Kerlikowske K, Buist DSM, Irwig L, Lee J, Miglioretti DL. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev 2013 May;22(5):946-61 PMID:23513042.

Caswell CL, Kerlikowske K, Shepherd JA, Cummings SR, Hu D, Huntsman S, Ziv E. High mammographic density in women of Ashkenazi Jewish descent. Breast Cancer Research 2013; 15(3):R40 (13 May 2013). PMID: 23668689.

Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli K, Miglioretti DL, O’Meara ES. Outcomes of screening mammography by frequency, breast density, postmenopausal hormone therapy. JAMA Intern Med 2013 May 13;173(9):807-16. PMID: 23552817.

Harvey JA, Gard CC, Miglioretti D, Yankaskas B, Kerlikowske K, Buist DSM, Geller B, Onega T. Reported Mammographic Density: Film-Screen vs. Digital Acquisition. Radiology 2013 March; 266(3):752-758. PMID:23249570

Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening Outcomes in Older U.S. Women Undergoing Multiple Mammograms in Community Practice: Does Interval, Age or Comorbidity Score Affect Tumor Characteristics or False Positive Rates? J Natl Cancer Inst 2013 March 6; 105(5):334-41. PMID: 23385442 

Goldman LE, Walker R, Hubbard R, Kerlikowske K. Timeliness of Abnormal Screening and Diagnostic Mammography Follow-up at Facilities Serving Vulnerable Women. Medical Care 2013 April;51(4):307-14. PMID: 23358386

2012

Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B.  Smoking and survival after breast cancer diagnosis:  a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov;136(2):521-33. PMID: 23053660.

Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DSM, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B. Radiologist Agreement of Mammographic Recall by Case Difficulty and Finding Type. J Am Coll of Radiol 2012 Nov; 9(11):788-94. PMID: 23122345. 

Yasmeen S, Hubbard RA, Romano PS, Zhu W, Geller BM, Onega T, Yankaskas BC, Miglioretti DL, Kerlikowske K. Risk of Advanced-Stage Breast Cancer among Older Women with Comorbidities. Cancer Epidemiol Biomarkers Prev 2012 Sep;21(9):1510-9 . PMID: 22744339

Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME. Relationship Between Mammographic Density and Breast Cancer Death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst 2012; Aug 22;104(16):1218-27. PMID: 22911616. 

Houssami N, Kerlikowske K. The impact of breast density on breast cancer risk and on breast screening. Current Breast Cancer Reports 2012;4(2):161-168. June 2012, Volume 4, Issue 2, pp 161-168.

van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DSM, Huang H, Heijnsdijk EAM, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years: A Comparative Modeling Study of Risk. Ann Intern Med 2012;156:609-617. PMID: 22547470.

Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, Miglioretti D, O’Meara E, Buist DSM, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt J.Risk Factors for Breast Cancer for Women Aged 40 to 49 Years: A Systematic Review and Meta-analysis. Ann Intern Med 2012;156:635-648. PMID: 22547473.

Buist DSM, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL. Screening mammography use among current, former and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev 2012 May;21(5):720-7. PMID: 22301831 PMC ID: 3348383.

Carney PA, Bogart TA, Geller BM, Haneuse S, Kerlikowske K, Buist DS, Smith R, Rosenberg R, Yankaskas BC, Onega T, Miglioretti DL. Association between time spent interpreting, level of confidence, and accuracy of screening mammography. AJR Am J Roentgenol 2012 April;198(4):970-8.  PMID: 22451568.

Shepherd JA, Kerlikowske K. Do fatty breasts increase or decrease breast cancer risk? Breast Cancer Res 2012;14:102 PMID: 22277587.

Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI . Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 2012;22(5):340-8. PMID: 22366170 PMC ID: 3338877. 

Goldman LE, Walker R, Miglioretti DL, Smith-Bindman R, Kerlikowske K. Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women. Medical Care 2012 March;50(3):210-16.  PMID: 22186768

Kerlikowske K. Screening mammography in women less than age 50 years. Current Opinion in Obstetrics and Gynecology. 2012 Feb;24(1):38-43 PMID: 22037165.

Carney PA, Cook AJ, Miglioretti DL, Feig SA, Bowles EA, Geller BM, Kerlikowske K, Kettler M, Onega T, Elmore JG. Use of clinical history affects accuracy of interpretive performance of screening mammography. J Clin Epidemiol, 2012 Feb;65(2):219-30. PMID: 22000816.

Karliner LS, Ma L, Hofmann M, Kerlikowske K. Language Barriers, Location of Care and Delays in Follow-up of Abnormal Mammograms. Medical Care 2012 Feb;50(2):171-8 PMID: 21993060.

Haneuse S, Buist DSM, Miglioretti DL, Anderson ML, Carney PA, Onega TL, Geller BM, Kerlikowske K, Rosenberg RD, Yankaskas BC, Elmore JG, Taplin S, Smith RA, Sickles EA. Mammographic interpretive volume and diagnostic mammography interpretation performance in community practice. Radiology Radiology. 2012 Jan;262(1):69-79. PMID: 22106351

 

2011

Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med 2011 Oct 18;155(8):481-92. PMID: 22007042; PMC ID: 3209800.

Kerlikowske K, Hubbard RA, Miglioretti DL, Geller B, Yankaskas BC, Lehman C, Taplin SH, Sickles EA. Comparative-effectiveness of digital vversus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med 2011 Oct 18;155(8):493-502. PMID: 22007043.

Rosenberg RD, Haneuse SJ, Geller BM, Buist DS, Miglioretti DL, Brenner RJ, Smith-Bindman R, Taplin SH, Breast Cancer Surveillance Consortium.
Timeliness of follow-up abnormal screening mammogram. variability of facilities. Radiology. 2011 Nov;261(2):404-13. PMID: 21900620 PMC ID: 3198220.

Kerlikowske K, Phipps AI. Breast density influences tumor subtypes and tumor aggressiveness (editorial). J Natl Cancer Inst, 2011 Aug 3;103(15):1143-5. PMID: 21795663 PMC ID: 3149045.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011 Jul 5;155(1):10-20. PMID: 21727289.

Shepherd J, Kerlikowske K, Ma L, Bo F, Duewer F, Fan B, Wang J, Malkov S, Vittinghoff E, Cummings S. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers and Prev 2011 Jul;20(7):1473-82. Epub 2011 May 24. PMID: 21610220 PMC ID: 3132306.

Houssami N, Abraham LA, Miglioretti DL, Sickles EA, Kerlikowske K, Buist DSM, Geller BM, Muss HB, Irwig L. Accuracy and Outcomes of Screening Mammography in Women With a Personal History of Early-Stage Breast Cancer . JAMA 2011; Feb 23;305(8):790-9. PMID: 21343578.

 Buist DSM, Anderson ML, Haneuse S, Sickles EA, Smith RA, Carney PA, Taplin SH, Rosenberg RD, Geller BM, Onega TL, Monsees BS, Bassett, LW, Yankaskas BC, Elmore JG, Kerlikowske K, Miglioretti DL. Influence of annual interpretive volume on screening mammography performance in the United States. Radiology, 2011 Apr;259(1):72-84. PMID: 21343539 PMC ID: 3064821.

Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes and Control, 2011 Mar;22(3):399-405. PMID: 21184265; PMC ID: 3042513.

Goldman LE, Walker R, Miglioretti DL, Smith-Bindman R, Kerlikowske K, National Cancer Institute Breast Cancer Surveillance Consortium. Accuracy of diagnostic mammography at facilities serving vulnerable women. Medical Care, 2011 Jan;49(1):67-75. PMID: 20966780

 

2010

Farhat G, Walker R, Buist DSM, Onega T, Kerlikowske K. Changes in Invasive Breast Cancer and Ductal Carcinoma In Situ Rates in Relation to The Decline in Hormone Therapy Use. JCO, J Clin Oncol. 2010 Dec 10;28(35):5140-6. PMID: 21060026; PMC ID: 3020688.

DeMartini W, Ichikawa L, Yankaskas B, Buist DS, Kerlikowske K, Geller B, Onega T, Rosenberg R, Lehman C. Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium (BCSC). J American College of Radiol, 2010 Nov;7(11):878-84. PMID: 21040870; PMC ID: 2994070.

Kerlikowske K. Epidemiology of Ductal Carcinoma In Situ. JNCI Monographs 2010;41:139-141. PMID: 20956818

Onega T, Bowles EJA, Miglioretti DL, Geller B, Carney PA, Yankaskas B, Kerlikowske K, Sickles EA, Elmore JE. Radiologists' perceptions of computer aided detection versus double reading for mammography interpretation. Academic Radiology, 2010;17:1217-26 PMID: 20832024

Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Research Treatment 2010 Sep 3. PMID: 20814817; PMC ID: 3059326.

Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, Carney PA, Kerlikowske K, Geller BM. Diagnosis of second breast cancer events after initial diagnosis of early-stage breast cancer. Breast Cancer Research Treatment, 2010 Aug 11. PMID: 20700648; PMC ID: 2976764.

Kerlikowske K, Cook A, Buist DSM, Cummings S, Vachon C, Vacek P, Miglioretti DL. Breast cancer risk by breast density, age, menopause, and postmenopausal hormone therapy use. JCO, 2010: Jul 19. PMID: 20644098; PMC ID: 2940400.

Taplin S, Abraham L, Geller B, Barlow WE, Buist D, Smith-Bindman R, Lehman C, Weaver D, Carney P, Yankaskas B. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography, J Natl Cancer Inst. 2010 Jul 21;102(14):1040-51. PMID: 20601590; PMC ID: 2907407.

Kerlikowske K. A call for evidence of benefits outweighing harms before implementing new technologies. (Editorial) Arch Intern Med, 2010;170:990-991. PMID: 20548014

Ichikawa LE, Barlow WE, Anderson ML, Taplin S Geller B, Brenner RJ. Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004, Radiology. 2010 Jul;256(1):74-82. PMID: 20505059; PMC ID: 2897687.

Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DSM. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers and Prev, 2010;19(6);1643-54. PMID: 20501751; PMC ID: 2882996.

Phipps AI, Ichikawa L, Bowles EJA, Carney PA, Geller BM, Kerlikowske K, Miglioretti DL, Buist DSM. Defining menopausal status in epidemiologic studies: an applied comparison of multiple approaches. Maturitas, 2010;66:PMID: 20494530; PMC ID: 2922404

Elmore JE, Jackson S, Abraham L, Miglioretti DL, Carney PA, Geller B, Yankaskas B, Kerlikowske K, Onega T, Osler N, Jarman, M, Rosenberg RD, Sickles E, Buist DSM. Radiologists' attitudes and use of mammography audit reports that are required by U.S. Congress. Academic Radiology, 2010;17(6):752-60. PMID: 20457418; PMC ID: 2894027.

Yankaskas BC. Haneuse S, Kapp JM, Kerlikowske K, Geller B, Buist DSM. Performance of first mammography examination in women younger Than 40 Years. JNCI, 2010;102. PMID: 20439838; PMC ID:2902813.

Aiello Bowles EJ, Sickles EA, Miglioretti, Carney PA, Elmore JG. Recommendation for short-interval follow-up exams after a probably benign assessment - Is clinical practice consistent with BI-RADS® guidance? AJR Am J Roentgenol. 2010 Apr;194(4):1152-9. PMID: 20308525; PMC ID: 2861652.

Laidevant AD, Malkov S, Flowers CI, Kerlikowske K, Shepherd JA. Compositional breast imaging using a dual-energy mammography protocol. Medical Physics, 2010;37(1):164-74. PMID: 20175478; PMC ID: 2801735

Chang CB, Lvoff NM, Leung JW, Brenner RJ, Joe BN, Tso HH, Sickles EA. Solitary dilated duct identified at mammography: outcomes analysis. AJR Am J Roentgenol. 2010 Feb;194(2):378-82. PMID: 20093599

2009

Malkov S, Wang J, Kerlikowske K, Cummings S, Shepherd JA. Single X-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. Medical Physics, 2009;36:5525-5536. PMID: 20095265; PMC ID: 2789112

Kerlikowske K. Evidence-based breast cancer prevention: the importance of individual risk. (Editorial) Ann Intern Med, 2009;151;750-752. PMID: 19920276

Venkatesan A, Chu P, Sickles E Kerlikowske K, Smith-Bindman R. Positive predictive value of specific mammography findings by reader and patient variables. Radiology, 2009;250:648-657. PMID: 19164116; PMC ID: 2680167.

 Cummings SR, Tice JA, Bauer S, Browner WS, Cuzik J, Ziv E, Vogel V, Shepherd J, Smith-Bindman R, Kerlikowske K. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. JNCI 2009;101:384-398. PMID: 19276457; PMC ID: 2720698.

Elmore JE, Jackson S, Abraham L, Miglioretti DL, Carney PA, Geller B, Yankaskas B, Kerlikowske K, Onega T, Rosenberg RD, Sickles E, Buist DSM.Variability in interpretive performance of screening mammography and radiologist characteristics associated with accuracy. Radiology, 2009; 253(3):641-651. PMID: 19864507; PMC ID: 2786197.

Miglioretti DL, Gard CC, Carney PA, Onega T, Buist DSM, Sickles EA, Kerlikowske K, Rosenberg RD, Yankaskas, BC, Geller BM, Elmore JG. When radiologists perform best: the learning curve in screening mammography interpretation. Radiology, 2009. Dec; 253(3):632-40. PMID: 19789234; PMC ID: 2786195.

Gallagher TH, Cook A, Brenner J, Carney PA, Miglioretti DL, Geller B, Kerlikowske K, Onega T, Rosenberg R, Yankaskas B, Elmore JG. Disclosing harmful mammography errors to patients. Radiology, 2009 Nov; 253(2):443-52. PMID: 19710002; PMC ID: 2770115.

 Menes T, Kerlikowske K, Jaffer S, Seger D, Miglioretti DL. Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium. Cancer Epidemiol Biomarkers and Prev. 2009 Nov;18(11):2822-8. PMID: 19900937; PMC ID: 2920735.

Cook AJ, Elmore JG, Miglioretti DL, Sickles EA, Bowles EJ, Cutter GR, Carney PA. Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors. J Clin Epidemiol. 2009 Sep 8. PMID: 19744825. PMC ID: 2837135.

Jackson SL, Taplin SH, Sickles EA, Abraham L, Barlow WE, Carney PA, Geller B, Berns EA, Cutter GR, Elmore JG. Variability of interpretive accuracy among diagnostic mammography facilities. J Natl Cancer Inst. 2009 Jun 3;101(11):814-27. PMID: 19470953. PMC ID: 2689871.

 Abraham LA, Geller BM, Yankaskas BC, Bowles EJA, Karliner LS, Taplin SH, Miglioretti DL. Accuracy of self-reported breast cancer among women undergoing mammography. Breast Cancer Research and Treatment. 2009 Mar 20. PMID: 19301119; PMC ID: PMC2784159.

 

2008

Kerlikowske K, Walker, R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DSM. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst. 2008;100:1724-1733. PMID: 19033562; PMC ID: 2734114.

Taplin S, Abraham L, Barlow WE, Fenton JJ, Berns EA, Carney PA, Cutter GR, Sickles EA, Carl D, Elmore JG. Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst. 2008;100(12):876-87. PMID: 18544742; PMC ID: 2430588.

Goldman LE, Haneuse SJ, Miglioretti DL, Kerlikowske K, Buist DS, Yankaskas B, Smith-Bindman R; National Cancer Institute Sponsored Breast Cancer Surveillance Consortium. An assessment of the quality of mammography care at facilities treating medically vulnerable populations. Med Care. 2008;46(7):701-8. PMID: 18580389; PMC ID 2674332.

Bowles EJ, Miglioretti DL, Sickles EA, Abraham L, Carney PA, Yankaskas BC, Elmore JG. Accuracy of short-interval follow-up mammograms by patient and radiologist characteristics. AJR Am J Roentgenol. 2008 May;190(5):1200-8. PMID: 18430832

Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model. Ann Intern Med 2008;148:337-347. PMID: 18316752

Smith-Bindman R, Miglioretti DL, Rosenberg RD, Reid RJ, Taplin SH, Geller BM, Kerlikowske K. Physician workload in mammography. AJR 2008;190:526-532. PMID: 18212242

 

2007

Karliner LS, Kerlikowske K. Ethnic disparities in breast cancer. Women’s Health 2007;3:679-68. PMID: 19803977

Hwang ES, Miglioretti DL, Ballard-Barbash R, Weaver DL, Kerlikowske K. Breast density predicts subsequent contralateral invasive disease following treatment of ductal carcinoma in situ. Cancer Epidemiol Biomarkers and Prev 2007;16:2587-93

 Kerlikowske K, Miglioretti DL, Buist DSM, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. JNCI 2007;99:1335-1339. PMID: 17698950

Miglioretti DL, Smith-Bindman R, Abraham L, Brenner RJ, Carney PA, Bowles EJ, Buist DS, Elmore JG. Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst. 2007;99(24):1854-63. PMID: 18073379

Leung JW, Sickles EA. Developing asymmetry identified on mammography: correlation with imaging outcome and pathologic findings. AJR 2007;188:667-75. PMID: 17312052

Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DSM, Vacek PM, Smith-Bindman R, Yankaskas BC, Carney PA, Ballard-Barbash R. Longitudinal measurement of clinical mammographic breast density improves estimation of breast cancer risk. JNCI 2007;99:386-95. PMID: 17341730

Karliner LS, Nápoles-Springer A, Kerlikowske K, Haas JS, Kaplan CP. Missed opportunities: Family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. JGIM 2007;22:308-314. PMID: 17356960; PMC ID: 1824768.

Haas JS, Miglioretti DL, Geller BM, Buist DSM, Nelson DE, Kerlikowske K, Carney PA, Dash S, Breslau ES, Ballerd-Barbash R. Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based Declines in hormone therapy use. JGIM 2007;22:68-73. PMID: 17351842; PMC ID: 1824785.

Carney PA, Abraham L, Miglioretti DL, Yabroff KR, Sickles EA, Buist DSM, Kasales CJ, Geller BM, Rosenberg RD, Dignan MB, Weaver DL, Kerlikowske K.Factors associated with imaging and procedural events used to detect breast cancer following screening mammography. AJR 2007;188:385-392. PMID: 17242246

Kerlikowske K. The mammogram that cried Wolfe. (Editorial) NEJM 2007;356:297-300. PMID: 17229958

Leung JW, Margolin FR, Dee KE, Jacobs RP, Denny SR, Schrumpf JD. Performance parameters for screening and diagnostic mammography in a community practice: are there differences between specialists and general radiologists? AJR Am J Roentgenol. 2007 Jan;188(1):236-41. PMID: 17179372

 

2006

Rosenberg RD, Yankaskas B, Abraham L, Sickles EA, ,Lehman C, Geller BM, Carney PA, Kerlikowske K, Buist DSM, Weaver D, Barlow WE, Ballard-Barbash R. Performance Benchmarks for screening mammography. Radiology 2006; 241:55-66. PMID: 16990671

Geller BM, Ichikawa L, Buist DSM, Sickles EA, Carney PA, Yankaskas B, Dignan M, Kerlikowske K, Yarbroff R, Barlow WE, Rosenberg RD. Improving the concordance of mammography assessment and management recommendations. Radiology 2006; 241:67-75. PMID: 16990672

Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff LT, Carney PA, Tice JA, Buist D, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.A prospective breast cancer risk prediction model among women undergoing screening mammography. JNCI 2006;98:1204-1214. PMID: 16954473

Haas JS, Geller BM, Miglioretti DL, Buist DSM, Nelson DE, Kerlikowske K, Carney PA, Breslau ES, Dash S, Canales MK, Ballerd-Barbash R. Changes in the newspaper coverage of hormone therapy with the release of new medical evidence. JGIM 2006;21:304-309. PMID: 16499542; PMC ID: 1484740.

Shepherd JA, Herve L, Landau J, Fan B, Kerlikowske K, Cummings SR. Clinical comparison of a novel breast DXA technique to mammographic densityof mammographic breast density. Medical Physics 2006;33:1490-98. PMID: 16752583

Smith-Bindman R, Quale C, Chu PW, Rosenberg RD, Kerlikowske K. Can Medicare billing claims data be used to assess mammography utilization among women aged 65 and older? Medical Care, 2006;44:463-70. PMID: 16641665

Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Ballard-Barbash R, Strzelczyk J, Dignan M Barlow WE, Beasley CM, Kerlikowske K. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 2006;144:541-553. PMID: 16618951

Weaver DL, Rosenberg RD, Barlow WE, Ichikawa L, Carney PA, Kerlikowske K, Buist DSM, Geller BM, Key CR, Maygarden SJ. Ballard-Barbash R. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006;106:732-742. PMID: 16411214

Kaplan CP, Haas JS, Perez-Stable EJ, Somkin C, Gregorich S, Des Jarlais G, Kerlikowske K. Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers and Prev 2006;15:162-166. PMID: 16434605

 

2005

Haas JS, Kaplan CP, Des Jarlais G, Gildengoin V, Perez-Stable EJ, Kerlikowske K. Perceived risk of breast cancer among women at average and increased risk. J Women's Health 2005;14:845-51. PMID: 16313212

Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population. Breast Cancer Res Treat 2005; 94:155-122. PMID: 16261410

Des Jarlais G, Kaplan CP, Haas JS, Gregorich S, Perez-Stable EJ, Kerlikowske K. Factors Affecting participation in a telephone survey among women from four racial/ethnic groups. Prev Med 2005;41:720-727. PMID: 15936066

Kerlikowske K, Creasman J, Leung J, Smith-Bindman R, Ernster VL. Differences in screening mammography outcomes among White, Chinese, and Filipino women . Arch Intern Med 2005;165:1862-68. PMID: 16157830

Haas JS, Kaplan CP, Brawarsky P, Kerlikowske K. Evaluation and outcomes of women with a breast lump and normal mammogram results. JGIM 2005;20:692-696. PMID: 16050876; PMC ID: 1490178.

Sickles EA, Miglioretti DL, Ballard-Barbash R, Geller BM, Leung JWT, Rosenberg RD, Smith-Bindman R, Yankaskas BC. Performance benchmarks for diagnostic mammography. Radiology 2005;235:775-790. PMID: 15914475

Shepherd JA, Herve L, Landau J, Fan B, Kerlikowske K, Cummings SR. Novel use of single x-ray absorptiometry for measuring breast density. Technol Cancer Res Treat 2005;4:173-82. PMID: 15773786

Smith-Bindman R, Ballard-Barbash R, Patnick J, Kerlikowske K. Comparing the performance of mammography screening mammography in the United States and the United Kingdom. J Med Screen 2005;12:50-54. PMID: 15814020

Smith-Bindman R, Chu PW, Quale C, Miglioretti DL Rosenberg RD, Cutter G, Geller B, Bacchettii P, Sickles EA, Kerlikowske K. Physician predictors of mammographic accuracy. JNCI 2005;97:358-67. PMID: 15741572

Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR. Are breast density and bone mineral density independent risk factors for breast cancer? JNCI 2005;97:368-74. PMID: 15741573

Yankaskas BC, Taplin SH, Ichikawa L, Geller BM, Rosenberg R, Carney PA, Kerlikowske K, Ballard-Barbash R, Cutter G, Barlow WE. Association between mammography timing and measures of screening performance in the U.S. Radiology 2005;234:363-373. PMID: 15670994

Kerlikowske K, Smith-Bindman R, Lynn A, Lehman C, Yankaskas BC, Ballard-Barbash R, Barlow WE, Voeks J, Geller BM, Carney PA, Yankaskas BC, Sickles EA. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology 2005;234:684-692. PMID: 15734926

 

2004

White E, Miglioretti D, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestricher N, Barlow W, Ballard-Barbash R, Taplin SH. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004 Dec 15;96(24):1832-9. PMID: 15601639

Ziv E, Tice J, Smith-Bindman R, Shepherd JA, Cummings SR, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers and Prev 2004;13:2090-2095. PMID: 15598766

Miglioretti DL, Rutter CM, Geller BM, Cutter G, Barlow WE, Rosenberg R, Weaver DL, Taplin SH, Ballard-Barbash R, Carney PA, Yankaskas BC, Kerlikowske K. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA. 2004;291:442-450. PMID: 14747501 

Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the Use of Post-Menopausal Hormone Therapy with the Publication of Clinical Trial Results. Ann Intern Med, 2004;140:184-8. PMID: 14757616

 

2003

Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, Bobo JK, Lee NC, Wallis MG, Patnick J, Kerlikowske K. Comparison of screening mammography in the United States and the United Kingdom. JAMA 2003;290:2129-2137. PMID: 14570948

Kerlikowske K, Smith-Bindman R, Ljung Britt-Marie, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med, 2003;139: 274-284. PMID: 12965983

Ziv E, Shepherd JA, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. JNCI 2003;95:556-558. PMID: 12671024

Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DSM, Barlow WE, Cutter G, Geller BM, Yankaskas B, Taplin, SH, Carney PA. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. JCO 2003;21:4314-4321. PMID: 14645420

Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH, Waldman F. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. JNCI 2003;95:1692-1702. PMID: 14625260

Kerlikowske K, Smith-Bindman R, Sickles EA. Short-interval follow-up mammography: Are we doing the right thing? (editorial) JNCI 2003;95:418-419. PMID: 12644528

Geller, BM, Kerlikowske K, Carney PA, Abraham LA, Yankaskas BC, Taplin SH, Ballard-Barbash R, Dignan MB, Rosenberg R, Urban N, Barlow WE.Mammography surveillance following breast cancer. Breast Cancer Research and Treatment 2003;81:107-115. PMID: 14572153

Carney PA, Miglioretti DL, Yankaskas B, Kerlikowske K, Rosenberg R, Rutter C, Geller, BM, Abraham LA, Dignan MB, Cutter G, Ballard-Barbash R. Individual and combined effects of age, breast density and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75. PMID: 12558355

 

2002

Burnside E, Sickles EA, Sohlich R, Dee KE. The differential value of comparison with previous examinations in diagnostic versus screening mammography. AJR 2002;179:1173-7. PMID: 12388494

Geller B, Barlow WE, Ballard-Barbash R, Ernster V, Yankaskas B, Sickles EA, Carney PA, Dignan MB, Rosenberg R, Urban N, Zheng Y, Taplin SH. Use of the American College of Radiology BI-RADS to report on the mammographic evaluation of women with signs and symptoms of breast disease. Radiology 2002;222:536-42. PMID: 11818625

Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver D, Cutter G, Yankaskas B, Rosenberg R, Carney PA, Kerlikowske K, Taplin S, Urban N, Geller B. Detection of DCIS in women undergoing screening mammography. JNCI. 2002;94:1546-54. PMID: 12381707

Prevrhal S., Shepherd JA, Smith-Bindman R, Cummings SR, Kerlikowske K. Accuracy of mammographic breast density analysis: results of formal operator training. Cancer Epidemiology, Biomarkers and Prevention. 2002;11:1389-1393. PMID: 12433716

Barlow WE, Lehman CD, Zheng Y, Ballard-Barbash R, Yankaskas B, Cutter G, Carney PA, Geller BM, Rosenberg, R, Kerlikowske K, Weaver D, Taplin SH.Performance of diagnostic mammography for women with signs or symptoms of breast cancer. JNCI. 2002;94:1151-1159. PMID: 12165640

Shepherd JA, Kerlikowske K, Smith-Bindman R, Genant HK, Cummings SR. Can dual X-ray absorptiometry accurately and precisely measure breast density? Radiology. 2002;223:554-557. PMID: 11997567

Taplin S, Ichikawa L, Kerlikowske K, Ernster V, Rosenberg R, Yankaskas B, Carney P, Geller B, Urban N, Dignan M, Ballard-Barbash R, Sickles EA.Concordance of Breast Imaging Reporting and Data System assessments and management recommendations in screening mammography. Radiology 2002;222:529-35. PMID: 11818624

Sickles EA, Wolverton DE, Dee KE. Performance parameters for screening and diagnostic mammography: specialist and general radiologists. Radiology 2002; 224:861-869. PMID: 12202726

Sohlich R, Sickles EA, Burnside E, Dee KE. Interpreting data from audits when screening and diagnostic mammography outcomes are combined. AJR Am J Roentgenol. 2002 Mar;178(3):681-6. PMID: 11856698

2001

Dee KE, Sickles EA. Medical audit of diagnostic mammography examinations: comparison with screening outcomes obtained concurrently. AJR 2001;176(3):729-33. PMID: 11222214

Haas J, Kaplan C, McMillan A, Esserman L. Does timely assessment affect the anxiety associated with an abnormal mammogram result? J Womens Health Gend Based Med 2001;10:599-606. PMID: 11559457

2000

Ernster V, Barclay JB, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality Among Women with Ductal Carcinoma In Situ of the Breast in the Population-based Surveillance, Epidemiology, and End Results Program. Arch Intern Med 2000;160(7):953-8. PMID: 10761960

Haas JS, Cook EF, Puopolo AL, Burstin HR, Brennan TA. Differences in the Quality of Care for Women with an Abnormal Mammogram or Breast Complaint. J Gen Intern Med 2000;15(5):321-8. PMID: 10840267.

Margolin FR, Leung J, Jacobs RP, Denny SR. Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital. AJR Am J Roentgenol. 2001;177:559-64. PMID: 11517047

Hunt KA, Sickles EA. Effect of Obesity on Screening Mammography: Outcomes Analysis of 88,346 Consecutive Examinations. AJR 2000;174(5):1251-5. PMID: 10789771ikowske K. Breast Cancer Screening. In Women and Health. San Diego: Academic Press, 2000.

Kerlikowske K, Ernster VL. Women Should Be Fully Informed of the Potential Benefits and Harms Before Screening Mammography. West J Med 2000;173:313-14. PMID: 11069863.

Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM. Dynamic High-spatial-resolution MR Imaging of Suspicious Breast Lesions: Diagnostic Criteria and Interobserver Variability. AJR 2000;175(1):35-43. PMID: 10882243

Leung JW, Sickles EA. Multiple Bilateral Masses Detected on Screening Mammography: Assessment of Need for Recall Imaging. AJR 2000;175(1):23-9. PMID: 10882241

Pearson KL, Sickles EA, Frankel SD, Leung JW. Efficacy of Step-oblique Mammography for Confirmation and Localization of Densities Seen on Only One Standard Mammographic View. AJR 2000;174(3):745-52. PMID: 10701619

Kerlikowske K, Carney P, Geller B, Mandelson MT, Taplin S, Malvin K, Ernster V, Urban N, Cutter G, Rosenberg R, Ballard-Barbash R. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med 2000;133:855-863. PMID: 11103055

Sickles EA. Successful Methods to Reduce False-positive Mammography Interpretations. Radiol Clin North Am 2000;38(4):693-700. PMID: 10943271

Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is Screening Mammography Effective in Elderly Women? Am J Med 2000;108(2):112-19. PMID: 11126304

Waldman FM, DeVries S, Chew K, Moore D, Kerlikowske K, Ljung BM. Chromosomal Alterations of Ductal Carcinomas In Situ and Their In Situ Recurrences. J Natl Cancer Inst 2000;92:313-20. PMID: 10675380

Warren Burhenne LJ, Wood SA, D'Orsi CJ, Feig SA, Kopans DB, O'Shaughnessy KF, Sickles EA, Tabar L, Vyborny CJ, Castellino RA. Potential Contribution of Computer-aided Detection to the Sensitivity of Screening Mammography. Radiology 2000;215(2):554-62. PMID: 10796939

 

1999

Ernster VL. Prophylactic Mastectomy in Women with a High Risk of Breast Cancer [letter; comment]. N Engl J Med 1999;340(23):1838; discussion 1839. PMID: 10366320

Ernster V, Kerlikowske K. Breast Cancer Screening. Lancet 1999;354:947.

Hunt KA, Rosen EL, Sickles EA. Outcome Analysis for Women Undergoing Annual Versus Biennial Screening Mammography: a Review of 24,211 Examinations. AJR 1999;173:285-9. PMID: 10430120

Kerlikowske K. Mammograms. In Encarta Encyclopedia. Redmond: Microsoft, 1999.

Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing Screening Mammography in Women Aged 70 to 79 Years Impact on Life Expectancy and Cost-effectiveness. J Am Med Assoc 1999;282:2156-63. PMID: 10591338

Rosen EL, Sickles E, Keating D. Ability of Mammography to Reveal Nonpalpable Breast Cancer in Women with Palpable Breast Masses. AJR 1999;172:309-12. PMID: 9930773

Sickles EA. Probably Benign Breast Lesions: When Should Follow-up be Recommended and What is the Optimal Follow-up Protocol? Editorial. Radiology 1999;213:11-12. PMID: 10540635

1998

Ernster VL. Ernster Responds (Invited reply to commentary). Am J Public Health 1998;88:834-5.

Ernster VL. Ernster Replies (letter). Am J Public Health 1998;88:841-2.

Kerlikowske K, Grady D, Barclay J, Frankel S, Ominsky S, Sickles E, Ernster V. Variability and Accuracy in Mammographic Interpretation Using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst 1998;90:1801-9. PMID: 9839520

Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors Associated with Women's Adherence to Mammography Screening Guidelines. Health Serv Res 1998;33:29-53. PMID: 9566176

Smith-Bindman R, Kerlikowske K. Is There a Downside to Elderly Women Undergoing Screening Mammography? J Natl Cancer Inst 1998;90:1322-3. PMID: 9747859

1997

Ernster VL, Barclay J. Increases in Ductal Carcinoma in Situ (Dcis) of the Breast in Relation to Mammography: A Dilemma. Monographs J Natl Cancer Inst 1997;22:151-6. PMID: 9709292

Ernster VL. Mammography Screening for Women Aged 40 Through 49--a Guidelines Saga and a Clarion Call for Informed Decision Making. Am J Public Health 1997;87:1103-6. PMID: 9240097

Ernster V. Epidemiology and Natural History of Ductal Carcinoma In Situ. In M. Silverstein (ed.) Ductal Carcinoma In Situ of the Breast. Williams & Wilkins, 1997;23-33.

Kerlikowske KM. Efficacy of Screening Mammography: Relative and Absolute Benefit. Monographs J Natl Cancer Inst 1997;22:79-86. PMID: 9709281

Kerlikowske KM, Barclay J. Outcomes of Modern Screening Mammography. Monographs J Natl Cancer Inst 1997;22:105-11. PMID: 9709285

Kerlikowske K, Barclay J, Grady D, Sickles EA, and Ernster V. Comparison of Risk Factors for Ductal Carcinoma In Situ and Invasive Breast Cancer. J Natl Cancer Inst 1997;89:76-82. PMID: 8978410

Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of Extending Screening Mammography Programs to Include Women 40-49. Ann Intern Med 1997;127:955-65. PMID: 9412300

Sickles EA. Breast Cancer Screening Outcomes in Women Ages 40-49: Clinical Experience with Service Screening Using Modern Mammography. Monographs Natl Cancer Inst 1997;22:99-104. PMID: 9709284

1996

Ernster VL. Screening Mammography for Women under 50: Considerations for Fully Informed Decision Making. Women's Health: Research on Gender, Behavior, and Policy 1996;2:255-8. PMID: 9453858

Ernster VL, Kerlikowske. Detection and Treatment of Ductal Carcinoma In Situ of the Breast (letter). J Am Med Assoc 1996;276:870-1.

Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson, Ic. Incidence and Treatment for Ductal Carcinoma In Situ of the Breast in the United States. J Am Med Assoc 1996;275:913-18. PMID: 8598618

Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of Age, Breast Density, and Family History on the Sensitivity of First Screening Mammography? J Am Med Assoc 1996;276:33-8. PMID: 8667536

Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood Ratios for Modern Screening Mammography. J Am Med Assoc 1996;276:39-43. PMID: 8667537

Kerlikowske K. Timeliness of Follow-up after Abnormal Screening Mammography. Breast Cancer Res Treat 1996;40:53-64. PMID: 8888152

Wolverton DE, Sickles EA. Clinical Outcome of Doubtful Mammographic Findings. AJR 1996;167:1041-5. PMID: 8819409

1995

Brown ML, Houn F, Sickles EA, Kessler LG. Screening Mammography in Community Practice: Positive Predictive Value of Abnormal Findings and Yield of Follow-up Diagnostic Procedures. AJR 1995;165:1373-7. PMID: 7484568

Curpen BN, Sickles EA, Sollitto RA, Ominsky SH, Galvin HB, Frankel SD. The Comparative Value of Mammographic Screening for Women 40-49 Years Old Versus Women 50-64 Years Old. AJR 1995;164:1099-1103. PMID: 7717212

Faulk RM, Sickles EA, Sollitto RA, Ominsky SH, Galvin HB, Frankel SD. Clinical Efficacy of Mammographic Screening in the Elderly. Radiology 1995;194:193-7. PMID: 7997552

Frankel SD, Sickles EA, Curpen BN, Sollitto RA, Ominsky SH, Galvin HB. Initial Versus Subsequent Screening Mammography: Comparison of Findings and their Prognostic Significance. AJR 1995;164:1107-9. PMID: 7717214

Kerlikowske K, Grady D, Ernster V. Benefit of Mammography Screening in Women Ages 40-49 Years: Current Evidence from Randomized Controlled Trials [letter]. Cancer 1995;76(9):1679-81. PMID: 8635076

Sickles EA. Management of Probably Benign Breast Lesions. Radiol Clin North Am 1995;33:1123-30. PMID: 7480660